Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Immunology|November 2, 2016
B-cell activation with CD40L or CpG measures the function of B-cell subsets and identifies specific defects in immunodeficient patientsEmiliano Marasco, Chiara Farroni, Simona Cascioli, et al.
Stem Cells and Development|July 19, 2014
Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cellsMaria Manuela Rosado, Maria Ester Bernardo, Marco Scarsella, et al.
Frontiers in Immunology|December 6, 2018
Dysregulated miR-155 and miR-125b Are Related to Impaired B-cell Responses in Down SyndromeChiara Farroni, Emiliano Marasco, Valentina Marcellini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumorsCarlo Leonetti, Marco Scarsella, Giuseppe Riggio, et al.
European Journal of Immunology|April 7, 2011
Switched memory B cells maintain specific memory independently of serum antibodies: the hepatitis B exampleM Manuela Rosado, Marco Scarsella, Elisabetta Pandolfi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 24, 2007
Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesisLucio Tentori, Pedro Miguel Lacal, Alessia Muzi, et al.
Frontiers in Immunology|August 9, 2021
Evolution of Human Memory B Cells From Childhood to Old AgeMichela Ciocca, Salvatore Zaffina, Ane Fernandez Salinas, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|April 2, 2011
Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomesMonica Marra, Giuseppina Salzano, Carlo Leonetti, et al.
The Journal of Clinical Investigation|October 13, 2007
Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effectErica Salvati, Carlo Leonetti, Angela Rizzo, et al.
Oncoimmunology|June 7, 2018
Choice of costimulatory domains and of cytokines determines CAR T-cell activity in neuroblastomaConcetta Quintarelli, Domenico Orlando, Iolanda Boffa, et al.
Pageof 7